(Q36740396)

16 August 2017

Haemodynamic effects of nifedipine and propranolol in patients with hypertrophic obstructive cardiomyopathy (English)

1 reference

hypertrophic obstructive cardiomyopathy

16 August 2017

0 references

1 reference

1 reference

Landmark K

1

1 reference

16 August 2017

Sire S

2

1 reference

16 August 2017

Thaulow E

3

1 reference

16 August 2017

Amlie JP

4

1 reference

16 August 2017

Nitter-Hauge S

5

1 reference

16 August 2017

language of work or name

1 reference

1 July 1982

1 reference

16 August 2017

British Heart Journal

1 reference

16 August 2017

48

1 reference

16 August 2017

19-26

1 reference

16 August 2017

1

1 reference

Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazem

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481196

Effects of propranolol on response to exercise in hypertrophic obstructive cardiomyopathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481196

Long-term propranolol therapy in muscular subaortic stenosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481196

Analysis of symptomatic course and prognosis and treatment of hypertrophic obstructive cardiomyopathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481196

Double-blind trial of propranolol and practolol in hypertrophic cardiomyopathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481196

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481196

Calcium-membrane interactions in the myocardium: effects of ouabain, epinephrine and 3',5'-cyclic adenosine monophosphate

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481196

Indirect assessment of myocardial oxygen consumption in the evaluation of mechanisms and therapy of angina pectoris

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481196

Prognosis and mortality of hypertrophic obstructive cardiomyopathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481196

Treatment of hypertrophic obstructive cardiomyopathy with verapamil

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481196

Effect of nifedipine on atrioventricular conduction as compared with verapamil. Intracardiac electrophysiological study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481196

Antianginal efficiency of nifedipine with and without a beta-blocker, studied with exercise test. A double-blind, randomized subacute study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481196

Treatment of hypertension with nifedipine, a calcium antagonistic agent

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481196

Arrhythmia as a cause of sudden death in hypertrophic cardiomyopathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481196

The Effect of Nifedipine on the Sinus and Atrioventricular Node of the Dog Heart after β-Adrenergic Receptor Blockade

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481196

Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481196

Improved diastolic function and systolic performance in hypertrophic cardiomyopathy after nifedipine

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481196

Membrane calcium current in ventricular myocardial fibres

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481196

Haemodynamic effects of intravenous verapamil at rest and during exercise in subjectively healthy middle-aged men

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481196

Acute and chronic effects of nifedipine in arterial hypertension

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481196

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481196

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481196

Effect of nifedipine on plasma renin, aldosterone and catecholamines in arterial hypertension

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481196

Amelioration of Angina Pectoris in Idiopathic Hypertrophic Subaortic Stenosis with Beta-Adrenergic Blockade

28 June 2018

1 reference

12 December 2020

Muscular subaortic stenosis. Prevention of outflow obstruction with propranolol

1 reference

12 December 2020

The Effect of Noradrenaline on the Calcium Uptake of the Sarcoplasmic Reticulum

1 reference

12 December 2020

Cardiohemodynamic effects of BAY a 1040 in the dog

1 reference

12 December 2020

Verapamil in cardiology

1 reference

12 December 2020

Calcium-antagonistic and Anti-arrhythmic Effects of Nifedipine on the Isolated Rat Atrium

1 reference

12 December 2020

A study of the verapamil-induced changes in conductivity and refractoriness and monophasic action potentials of the dog heart in situ

1 reference

12 December 2020

Nifedipine, a new antihypertensive with rapid action

1 reference

12 December 2020

Arrhythmia in hypertrophic cardiomyopathy: Exercise and 48 hour ambulatory electrocardiographic assessment with and without beta adrenergic blocking therapy

1 reference

12 December 2020

Left ventricular relaxation and filling pattern in different forms of left ventricular hypertrophy: an echocardiographic study

1 reference

12 December 2020

Hypertrophic cardiomyopathy: a disease in search of its own identity

1 reference

12 December 2020

EFFECTS OF BETA ADRENERGIC BLOCKADE ON THE CIRCULATION WITH PARTICULAR REFERENCE TO OBSERVATIONS IN PATIENTS WITH HYPERTROPHIC SUBAORTIC STENOSIS

1 reference

12 December 2020

ISOPROTERENOL AND CARDIOVASCULAR PERFORMANCE

1 reference

12 December 2020

MUSCULAR SUBAORTIC STENOSIS; THE INTERRELATION OF WALL TENSION, OUTFLOW TRACT "DISTENDING PRESSURE" AND ORIFICE RADIUS

1 reference

12 December 2020

Identifiers

DOI

10.1136/HRT.48.1.19

1 reference

16 August 2017

1 reference

16 August 2017

1 reference